sb 203580 has been researched along with Cardiac Failure in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liang, T; Liu, M; Lu, L; Wang, ZL; Zhang, PY; Zhang, Q | 1 |
Bernstein, HS; Gaur, M; Pedersen, A; Prasad, M; Ritner, C; Sievers, R; Yeghiazarians, Y | 1 |
Adams, V; Döring, C; Erbs, S; Hambrecht, R; Kränkel, N; Labeit, S; Linke, A; Müller-Werdan, U; Schuler, G; Wisloff, U; Witt, CC | 1 |
Bloem, LJ; Esterman, M; Fouts, R; Lemke, LE; Sandusky, G; Vlahos, CJ | 1 |
Adachi, S; Fujita, M; Hasegawa, K; Iwai-Kanai, E; Kihara, Y; Sasayama, S; Sawamura, T; Toyokuni, S; Yanazume, T | 1 |
Adams, V; Baur, A; Gielen, S; Hambrecht, R; Linke, A; Nehrhoff, B; Schuler, G; Schulze, PC; Späte, U | 1 |
6 other study(ies) available for sb 203580 and Cardiac Failure
Article | Year |
---|---|
MAPK pathway regulated the cardiomyocyte apoptosis in mice with post-infarction heart failure.
Topics: Animals; Apoptosis; Blotting, Western; Caspase 12; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Fluorescent Antibody Technique; Heart Failure; Heat-Shock Proteins; Hypertrophy, Left Ventricular; Imidazoles; Male; MAP Kinase Kinase 4; Mice; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Phosphoproteins; Pyridines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transcription Factor CHOP; Up-Regulation | 2017 |
Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes.
Topics: Animals; Cell Differentiation; Cell Survival; Cell Transplantation; Cells, Cultured; Embryonic Stem Cells; Heart Failure; Humans; Imidazoles; Mice; Mice, SCID; Muscle Development; Myocardial Contraction; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Pyridines; Time Factors; Troponin T; Ventricular Myosins | 2010 |
Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility.
Topics: Animals; Animals, Newborn; Blotting, Western; Echocardiography; Flavonoids; Gene Expression; Heart Failure; Imidazoles; Mitogen-Activated Protein Kinase 1; Models, Animal; Muscle Proteins; Myocardium; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Inbred WKY; RNA Interference; RNA, Messenger; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Troponin I; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; Ventricular Dysfunction, Left | 2007 |
Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart.
Topics: Adult; Blotting, Western; Enzyme Inhibitors; Female; Fluorescent Antibody Technique; Heart Failure; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Male; Microscopy, Confocal; Middle Aged; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Isoforms; Protein Serine-Threonine Kinases; Pyridines; Sarcomeres; Signal Transduction | 2001 |
Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes.
Topics: Animals; Animals, Newborn; Apoptosis; Cells, Cultured; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Heart Failure; Heart Ventricles; Imidazoles; Immunohistochemistry; In Situ Nick-End Labeling; Intracellular Membranes; Membrane Potentials; Mitochondria; Mitogen-Activated Protein Kinases; Norepinephrine; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Rats; Rats, Inbred Dahl; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Signal Transduction; Transfection | 2001 |
Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study.
Topics: Aged; Animals; Antioxidants; Blotting, Western; Case-Control Studies; Cytokines; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Heart Failure; Humans; Imidazoles; Interferon-gamma; Interleukin-1; Male; Mitogen-Activated Protein Kinase 6; Mitogen-Activated Protein Kinases; Muscle, Skeletal; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Proline; Pyridines; Rats; Signal Transduction; Thiocarbamates; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |